(NASDAQ: TWST) Twist Bioscience's forecast annual revenue growth rate of 17.89% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.62%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.21%.
Twist Bioscience's revenue in 2025 is $362,273,000.On average, 12 Wall Street analysts forecast TWST's revenue for 2026 to be $26,896,224,571, with the lowest TWST revenue forecast at $25,353,399,328, and the highest TWST revenue forecast at $28,457,158,091. On average, 9 Wall Street analysts forecast TWST's revenue for 2027 to be $31,596,529,801, with the lowest TWST revenue forecast at $29,237,021,242, and the highest TWST revenue forecast at $33,527,475,791.
In 2028, TWST is forecast to generate $35,530,854,892 in revenue, with the lowest revenue forecast at $34,137,724,743 and the highest revenue forecast at $36,576,306,113.